Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer

Deborah A. Fisher; Nicole Princic; Lesley Ann Miller-Wilson; Kathleen Wilson; Kathryn DeYoung; A. Burak Ozbay; Paul Limburg

doi:10.1007/s00384-021-04055-w

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer

Deborah A. Fisher, Nicole Princic, Lesley Ann Miller-Wilson, Kathleen Wilson, Kathryn DeYoung, A. Burak Ozbay, Paul Limburg

Gastroenterology and Hepatology

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: This study examined adherence to screening for fecal immunochemical test (FIT). Methods: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. Results: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. Conclusion: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence.

Original language	English (US)
Pages (from-to)	719-721
Number of pages	3
Journal	International Journal of Colorectal Disease
Volume	37
Issue number	3
DOIs	https://doi.org/10.1007/s00384-021-04055-w
State	Published - Mar 2022

Keywords

Colorectal neoplasms
Guideline adherence
Mass screening

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1007/s00384-021-04055-w

Cite this

@article{e5b45f78b83f4ea39bda23d40e5d4170,

title = "Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer",

abstract = "Purpose: This study examined adherence to screening for fecal immunochemical test (FIT). Methods: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. Results: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. Conclusion: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence.",

keywords = "Colorectal neoplasms, Guideline adherence, Mass screening",

author = "Fisher, {Deborah A.} and Nicole Princic and Miller-Wilson, {Lesley Ann} and Kathleen Wilson and Kathryn DeYoung and Ozbay, {A. Burak} and Paul Limburg",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2022",

month = mar,

doi = "10.1007/s00384-021-04055-w",

language = "English (US)",

volume = "37",

pages = "719--721",

journal = "International Journal of Colorectal Disease",

issn = "0179-1958",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer

AU - Fisher, Deborah A.

AU - Princic, Nicole

AU - Miller-Wilson, Lesley Ann

AU - Wilson, Kathleen

AU - DeYoung, Kathryn

AU - Ozbay, A. Burak

AU - Limburg, Paul

PY - 2022/3

Y1 - 2022/3

N2 - Purpose: This study examined adherence to screening for fecal immunochemical test (FIT). Methods: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. Results: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. Conclusion: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence.

AB - Purpose: This study examined adherence to screening for fecal immunochemical test (FIT). Methods: Adults (≥ 50–75) with a FIT between 1/1/2014 and 6/30/2019 in MarketScan administrative claims were selected (index = earliest FIT). Patients were followed for 10 years pre- and 3 years post-index. Patients at increased risk for CRC or with prior screening were excluded. Year over year adherence was measured post-index. Results: Of 10,253 patients, the proportion adherent to repeat testing at year 2 was 23.4% and 10.6% at year 3. Of 76.6% not adherent in year 2, 5.4% were adherent in year 3. Conclusion: Results suggest adherence to FIT tests is poor, minimizing potential benefits. Future studies are needed to consider alternative test options and whether more choice will improve long-term adherence.

KW - Colorectal neoplasms

KW - Guideline adherence

KW - Mass screening

UR - http://www.scopus.com/inward/record.url?scp=85118381409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118381409&partnerID=8YFLogxK

U2 - 10.1007/s00384-021-04055-w

DO - 10.1007/s00384-021-04055-w

M3 - Article

C2 - 34729622

AN - SCOPUS:85118381409

SN - 0179-1958

VL - 37

SP - 719

EP - 721

JO - International Journal of Colorectal Disease

JF - International Journal of Colorectal Disease

IS - 3

ER -

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this